Developing a novel fluorescent imaging point-of-care diagnostic for Mycobacteria
Files
Item Status
Embargo End Date
Date
Authors
Long, Joanna
Abstract
Tuberculosis (TB) is a major infective cause of death globally, with the greatest burden
falling to those countries with lower socioeconomic status. The World Health
Organisation aims to End TB by 2035, but improved point-of-care diagnostics are
needed to make this happen. In particular, this will help rural populations in low and
middle income countries to access diagnostics easily and more quickly, thereby
reducing the spread of the disease. Smear microscopy has been the cornerstone of
TB diagnostics for a century but processing techniques, biosafety and the microscopy
infrastructure make it difficult to translate directly to the point-of-care.
This thesis addresses the development of a novel point of care diagnostic test for the
rural, low and middle income region. Three issues have been addressed
independently including the improved labelling of Mycobacterium species, a novel
filtering lens for use with a smartphone microscope and the design of a new sputum
collecting and imaging device.
It has been demonstrated that a novel fluorescent stain that is specific for
Mycobacterium can label within seconds, without further wash or processing steps.
The rate of labelling is dependent on the environment that the Mycobacteria is
exposed to, with desiccating conditions resulting in the quickest labelling.
The development of an integrated filtering lens, which combines both a lens and filter
into one component has enabled fluorescent Mycobacterium to be imaged with a
smartphone microscopy system.
The designed device, that can capture a sputum sample, process and image it, would
negate the need for screening samples to be sent away to microscopy level suites.
The design process achieved the designs, incorporated the novel fluorescent stains
and the integrated filtering lens.
The work demonstrated in this thesis shows a potential solution for TB diagnostics at
the POC. While further work is needed in each of the areas discussed, such as
manufacturing and iterating the final design, a device similar to the one proposed
would disrupt the POC diagnostic space. However, the biggest challenge for all POC
diagnostics is integrating technology into healthcare systems and embedding it in
local culture so that patients and healthcare providers want to use the test.
Collaborating and working in partnership will be the key to any TB POC future success.
This item appears in the following Collection(s)

